New MRI techniques can help track treatment progress in muscle diseases like SMA.
This study looked at how a special kind of MRI can show changes in the spinal cord of patients with spinal muscular atrophy (SMA) who are receiving treatment. The researchers found that children treated with nusinersen, a medicine for SMA, had increases in the size of their spinal cord over time, which matched improvements in their movement abilities. Adults showed stable spinal cord measurements but still had some improvement in their function. The MRI results suggest that these measures can be useful for understanding how well the treatment is working. Think of it like using a fitness tracker to see how your exercise routine is helping you get stronger.
This information is important for SMA patients and their caregivers because it shows how doctors can use MRI to monitor treatment effects in a non-invasive way, meaning no surgery or needles are needed. Parents of young children with SMA might feel hopeful knowing that their kids are showing positive changes with treatment. For adults with SMA, understanding that some improvements are possible can encourage them to stick with their therapy. Healthcare providers can use these MRI techniques to better assess their patients' progress and adjust treatments accordingly. Overall, these findings can help everyone involved in SMA care to feel more confident about the treatment journey.
The study involved only a small number of patients, which means we need more research to confirm these findings across many people. While the MRI showed some positive trends, not all adult patients had the same improvements as children, so results may vary. It’s important for patients and caregivers to discuss these findings with their healthcare team to understand what it means for individual treatment plans.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.